癌症中的细胞外囊泡:金或特洛伊木马
Tao Han1, Qian Hao2,3, Tengfei Chao4
1Institutes of Health Central Plains, Xinxiang Key Laboratory for Molecular Oncology, Xinxiang Medical University, Xinxiang 453003, China.
Journal of molecular cell biology
|May 26, 2024
概括
细胞外囊泡 (EVs) 调解细胞通信,并影响癌症的进展. 这些天然纳米粒子可以被设计为向癌症治疗,提供一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 纳米技术 纳米技术
背景情况:
- 细胞间通信对于生物过程至关重要,涉及直接接触和分泌因素.
- 细胞外囊泡 (EVs) 是细胞对细胞和细胞对环境信号传递的关键媒介.
- 来自瘤的EVs影响瘤微环境,促进癌症的进展和治疗耐药性.
研究的目的:
- 审查电动汽车的生物发生和回收.
- 讨论电动汽车在癌症发展中的多方面的作用.
- 突出电动汽车作为向癌症治疗输送系统的潜力.
主要方法:
- 关于EV生物发生,癌症中的功能和治疗应用的文献综述.
- 对针对药物和核酸输送的电动汽车工程研究的分析.
- 在瘤学中对EV介导细胞间通信的当前知识的综合.
主要成果:
- EVs与癌细胞存活,增殖,转移,免疫逃避和抵抗有关.
- 工程电动汽车展示了针对化学疗法药物,核酸和蛋白质的向输送的潜力.
- 电动汽车可以进行修改,以增强瘤向和治疗有效载荷的传递.
结论:
- 电动瘤在癌症进展和瘤微环境中发挥着重要作用.
- 电动汽车是开发向癌症治疗的有希望的平台.
- 进一步研究电动汽车的工程和应用对于临床转化至关重要.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Intralumenal Vesicles and Multivesicular Bodies
3.5K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.5K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


